{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T23:34:02Z","timestamp":1773099242340,"version":"3.50.1"},"reference-count":13,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2020,10,22]],"date-time":"2020-10-22T00:00:00Z","timestamp":1603324800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccines"],"abstract":"<jats:p>(1) Background: Vaccination of solid organ transplant (SOT) candidates and recipients is vital to decrease infection-related morbidity and mortality. Here we describe our heart and lung transplant programs\u2019 rates of completion of hepatitis B and pneumococcal vaccinations and identify potential opportunities for improvement. (2) Methods: This is a single-center retrospective study that included all heart and lung transplant recipients between 1 July 2013 and 31 July 2018. We assessed demographics, causes of organ failure, pretransplant hepatitis B immune status, and completion rates for hepatitis B vaccine series, pneumococcal conjugate vaccine (PCV13), and pneumococcal polysaccharide vaccine (PPSV23). (3) Results: A total of 41 patients were included in the heart transplant cohort. Twelve (29.3%) had baseline hepatitis B immunity. Only 8\/29 (27.6%) completed the entire 3-dose hepatitis B vaccination series pretransplant. Pretransplant PCV13 and PPSV23 vaccination rates were 58.5% (24\/41) and 48.8% (20\/41), respectively; no additional patients received PCV13 or PPSV23 post-transplant. In the heart transplant cohort, a majority (82.9%) of patients were evaluated by the Transplant Infectious Diseases consultative service (TxID) pretransplant, and this had a statistically significant association with increased pneumococcal vaccination rates (p = 0.0017, PCV13 and p = 0.0103, PPSV23). In total, 55 patients were included in the lung transplant cohort. Five (9.1%) had baseline hepatitis B immunity; 33\/50 (66.0%) completed the hepatitis B vaccine series in the pretransplant setting. Pretransplant PCV13 and PPSV23 vaccination rate was 40.0% (22\/55) and 69.1% (38\/55), respectively. There was only a 47.3% and 72.3% completion rate overall in the post-transplant setting. (4) Conclusions: There continues to be a need for a comprehensive and coordinated effort to increase vaccine adherence for all SOT candidates in the pretransplant setting.<\/jats:p>","DOI":"10.3390\/vaccines8040622","type":"journal-article","created":{"date-parts":[[2020,10,22]],"date-time":"2020-10-22T10:27:58Z","timestamp":1603362478000},"page":"622","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["An Analysis of Adherence to Vaccination Recommendations in a Thoracic Organ Transplant Cohort"],"prefix":"10.3390","volume":"8","author":[{"given":"Deeksha","family":"Jandhyala","sequence":"first","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine, Medical University of South Carolina, Charleston, SC 29425, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica D.","family":"Lewis","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine, Medical University of South Carolina, Charleston, SC 29425, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2020,10,22]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"e13563","DOI":"10.1111\/ctr.13563","article-title":"Vaccination of solid organ transplant candidates and recipients: Guidelines from the American society of transplantation infectious diseases community of practice","volume":"33","author":"Kumar","year":"2019","journal-title":"Clin. Transplant."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1128\/CMR.16.3.357-364.2003","article-title":"Vaccinations for Adult Solid-Organ Transplant Recipients: Current Recommendations and Protocols","volume":"16","author":"Duchini","year":"2003","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1007\/BF00865476","article-title":"Attenuated varicella virus vaccine in children with renal transplants","volume":"8","author":"Zamora","year":"1994","journal-title":"Pediatr. Nephrol."},{"key":"ref_4","first-page":"11","article-title":"Immunization and organ transplant donors and recipients","volume":"20","author":"Grabenstein","year":"2001","journal-title":"Pharm. Pract. Manag. Q."},{"key":"ref_5","first-page":"2738","article-title":"Influenza vaccine does not cause rejection after cardiac transplantation","volume":"25","author":"Kobashigawa","year":"1993","journal-title":"Transplant. Proc."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"e13160","DOI":"10.1111\/tid.13160","article-title":"Infectious diseases pre-transplant evaluation improves vaccination rates for liver transplant candidates","volume":"21","author":"Pineda","year":"2019","journal-title":"Transpl. Infect. Dis."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.jcv.2015.04.011","article-title":"Considerable decrease in antibodies against hepatitis B surface antigen following kidney transplantation","volume":"68","author":"Moal","year":"2015","journal-title":"J. Clin. Virol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/ajt.12987","article-title":"High prevalence of hepatitis B nonimmunity in vaccinated pediatric liver transplant recipients","volume":"15","author":"Leung","year":"2015","journal-title":"Am. J. Transplant."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1111\/ajt.13187","article-title":"Solid Organ Transplantation from Hepatitis B Virus-Positive Donors: Consensus Guidelines for Recipient Management","volume":"15","author":"Huprikar","year":"2015","journal-title":"Am. J. Transplant."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/ajt.12025","article-title":"OPTN\/SRTR 2011 Annual Data Report: Deceased organ donation","volume":"13","author":"Israni","year":"2013","journal-title":"Am. J. Transplant."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1111\/j.1600-6143.2007.01668.x","article-title":"Immunogenicity of pneumococcal vaccine in renal transplant recipients\u2013three year follow-up of a randomized trial","volume":"7","author":"Kumar","year":"2007","journal-title":"Am. J. Transplant."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1097\/00042737-200104000-00010","article-title":"Immunogenicity of two accelerated hepatitis B vaccination protocols in liver transplant candidates","volume":"13","author":"Engler","year":"2001","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1708-8305.1995.tb00661.x","article-title":"Accelerated Schedule for Hepatitis B Immunization","volume":"2","author":"Bock","year":"1995","journal-title":"J. Travel Med."}],"container-title":["Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-393X\/8\/4\/622\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T10:26:04Z","timestamp":1760178364000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-393X\/8\/4\/622"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,22]]},"references-count":13,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["vaccines8040622"],"URL":"https:\/\/doi.org\/10.3390\/vaccines8040622","relation":{},"ISSN":["2076-393X"],"issn-type":[{"value":"2076-393X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,22]]}}}